Document:

EX-10.42

 Exhibit 10.42 

OLD DOMINION ELECTRIC COOPERATIVE 

AMENDED AND RESTATED DEFERRED 

COMPENSATION PENSION RESTORATION PLAN 

WHEREAS, Old Dominion Electric Cooperative (the “Cooperative”) has previously adopted the Deferred Compensation Pension
Restoration Plan for the benefit of certain employees of the Cooperative who may have the need for supplemental nonqualified deferred compensation payments to them because of limitations in the federal pension law relating to allowable payments from
qualified pension plans, and 
 WHEREAS, the Cooperative wishes for the payments that would otherwise be paid in pension benefits to
be paid by the cooperative as deferred compensation benefits, to the extent allowed by this plan and as provided in existing federal regulations. 

NOW THEREFORE, the Cooperative adopts this Amended and Restated Deferred Compensation Pension Restoration Plan effective
January 1, 2015, as provided below: 
 Intent and Construction. This Amended and Restated Deferred Compensation Pension
Restoration Plan (the “Deferred Compensation PRP”) is intended to be an unfunded and unsecured plan sponsored and maintained by the Cooperative primarily for the purpose of providing deferred compensation for a select group of management
or highly compensated employees of the Cooperative. 
 1. Definitions. In addition to terms defined in quotations in
parentheticals, the following definitions shall apply for purposes of the Plan: 
 “Actuarial Equivalent” means a benefit of equivalent
present value as of the date payment commences to a stated benefit value under the Plan, determined in accordance with Section 21 of the RS Plan (or successor provision). 

“Annual Compensation” means the total of all compensation paid by the Cooperative to the Participant in a calendar year including wages,
salary, and any other benefit of monetary value (whether paid in cash or otherwise), such as for example, the cost of any fringe, welfare or pension benefit. 

“Beneficiary” shall mean the beneficiary of a Participant designated pursuant to Section 8(d). 

“Board” means the Board of Directors of the Cooperative. 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Deferred Compensation PRP” or the “Plan” means this Amended and Restated Deferred Compensation Pension Restoration Plan of
the Cooperative. 

 “Disability” or “Disabled” means the following conditions are met: 

(a) The Participant satisfies the requirements necessary for the receipt of total disability benefits under the Long-Term Disability Plan for
Employees of NRECA Member Systems (the “LTD Plan”), as the LTD Plan may be amended from time to time (whether or not the Cooperative for whom the Participant was employed actually
participates in the LTD Plan); and 
 (b) The Participant has continued to make Participant contributions to the RS Plan, if required, for
the six-month period commencing with the first day of the month coincident with or next following the date his active employment ceased. 

“Effective Salary” means the same as defined in Paragraph 2.10 of the RS Plan. 

“Eligible Cooperatives” shall consist of those Cooperatives that: 

(a) Adopt the Amended and Restated Deferred Compensation PRP prior to January 1, 2015, provided they have an employee that is eligible to
participate no later than December 31, 2014, or 
 (b) Did not adopt the Amended and Restated Deferred Compensation PRP prior to
January 1, 2015, but who following 2014 subsequently identify an employee as having compensation as defined by the Cooperative’s RS Plan in excess of the applicable Code Section 401(a)(17) maximum compensation amount for benefits
earned during the 2014 Plan Year, and who subsequently adopt the Deferred Compensation PRP prior to December 31, 2015 retroactive to January 1, 2015. Such Cooperative will become eligible effective January 1, 2015, provided the
covered employee or employees are part of the Grandfathered Group Participants, and provided further the Cooperative agrees to pay to the RS Plan trust amounts attributable to compensation in excess of the Code Section 401(a)(17) limits that
would have been paid to the trust if the employee had begun participation in the first year the employee was eligible to participate. 

“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended, including regulations and applicable authorities
promulgated thereunder. 
 “Final Average Salary” means the same as the definition of Final Average Salary of Paragraph 2.13 of the RS Plan
(or successor provision). 
 “Grandfathered Group Participants” means those employees of an Eligible Cooperative who satisfy the
eligibility criteria below as of and no later than December 31, 2014, who are: 
 (a) A Participant in their Cooperative’s current
Deferred Compensation PRP; 

  
 2 

 (b) Eligible to participate in the Amended and Restated Deferred Compensation PRP prior to
December 31, 2014, because they: 
  

	 	(1)	Have or previously had compensation as defined by the Cooperative’s RS Plan in excess of the applicable Code Section 401(a) (17) limit for benefits earned prior to January 1, 2015, based on 2014 or
earlier salary as determined no later than December 31, 2015; and/or 

  

	 	(2)	Have a pension limitation under Code Section 415 occurring prior to January 1, 2015, and they have attained their Normal Retirement Date and elected to commence benefits under the RS Plan; and,

 (c) Are designated in writing by the Cooperative’s Board no later than December 31, 2015 as eligible to
participate in the Amended and Restated Deferred Compensation PRP as part of a “select group of management or highly compensated employees” as such term is defined in ERISA, and as provided in Schedule A attached to and made a part of this
Plan. 
 “Initial Vesting Date” means the date on which the substantial risk of forfeiture first lapses. 

“NRECA” means the National Rural Electric Cooperative Association. 

‘‘Normal Retirement Date” means the date designated by the Cooperative in its RS Plan Adoption Agreement. 

“Participant” means an employee of the Cooperative designated by the Board as a member of a select group of management or highly compensated
employees who have been designated as an eligible Participant in the Deferred Compensation PRP. 
 ‘‘Pension Limitation” means the
difference between the single sum equivalent of (i) the Participant’s accrued benefit from the RS Plan as calculated by NRECA without limitations provided in Sections 401(a)(17) and 415 of the Code, and (ii) the Participant’s
accrued benefit from the RS Plan as calculated by NRECA after application of the limitations of Sections 401(a)(17) and 415 of the Code, each of which is calculated at the time a Participant is entitled to a payment hereunder. For purposes of
determining a Participant’s Pension Limitation, the definitions and rules in the RS Plan shall apply to this Plan, unless otherwise provided herein. For example, a Participant’s final average pay shall be based on “Final Average
Pay” as defined in the RS Plan. 
 “Plan Year” means the 12-month period beginning on January 1 and ending on
December 31. 
 “RS Plan Benefit Election Date” means the date on or after a Participant’s Normal Retirement Date on which a
Participant elects to commence benefits from the RS Plan but has not separated from service and thus may continue to accrue benefits under the RS Plan. 

  
 3 

 “Retirement Security Plan or RS Plan” means the Retirement Security Plan sponsored by NRECA as
adopted by the Cooperative that has adopted this Amended and Restated Deferred Compensation PRP. 
 “Severance Pay Limit” is an amount
equal to the lesser of (i) the frozen benefit under the Severance Pay PRP, or (ii) twice the Participant’s Annual Compensation for the year immediately preceding the year in which the earlier of the Participant’s termination of
employment with the Cooperative less the amount of any other severance pay benefits paid by the Cooperative to the Participant. The Cooperative shall have the sole responsibility for determining the maximum amount of benefit attributable to the
Severance Pay PRP and informing NRECA of that determination. In the event a Participant’s Deferred Compensation PRP benefit vests before the Severance Pay PRP benefit is payable, for
purposes of calculating the Deferred Compensation PRP benefit, the Severance Pay Limit shall be determined as of the date the Deferred Compensation PRP benefit substantial risk of forfeiture lapses. Such determination shall be based on the
applicable actuarial assumption and methodologies used by the RS Plan. 
 “Severance Pay PRP” means the Amended and Restated Severance Pay
Pension Restoration Plan adopted by the Cooperative that provides certain severance benefits subject to the provisions of Section 409A of the Code relating to the time and form of benefit payments. 

“Subsequent Vesting Date” means a vesting date occurring after the Initial Vesting Date. 

2. Participation. 

(a) The Participants in the Deferred Compensation PRP eligible for benefits shall be Grandfathered Group Participants who are a select group of
management or highly compensated employees of the Eligible Cooperative whose compensation exceeds the limits of Section 401(a)(17) of the Code and/or whose benefit exceeds the limits of Section 415 of the Code and who are designated in
writing by the Board as Participants on the attached Schedule A, and who on the date of their attainment of the Normal Retirement Date, or upon such other date as the Board may designate, have a Pension Limitation, as defined in Section 1 of
this Deferred Compensation PRP, applied to reduce the amount of payment that would otherwise be payable by the RS Plan sponsored by NRECA. An individual whose Cooperative is not eligible for a funding credit for the individual through the RS Plan
shall not be considered eligible to participate in the Plan, regardless of whether they are identified or were identified as eligible to participate by the Cooperative or in this Plan document. 

(b) The Plan must be adopted by the Cooperative’s Board in the same Plan Year in which the Participant becomes eligible for participation
in the Plan, including the case of a Participant that becomes eligible for participation after reaching his Normal Retirement Date. Notwithstanding the foregoing, only a Cooperative that is an Eligible Cooperative may adopt the Plan and only with
respect to Grandfathered Group Participants. 

  
 4 

 3. Benefit Payment. 

(a) The Deferred Compensation PRP Benefit for a Participant payable under the Deferred Compensation PRP is the amount of the Participant’s
Pension Limitation minus the Participant’s Severance Pay Limit. 
 (b) The single lump sum for payment shall be the Actuarial Equivalent
of the Pension Limitation minus the Severance Pay Limit. 
 (c) In determining the Participant’s pension benefit from the RS Plan to
determine the Pension Limitation, there shall be included in the calculation amounts paid in cash to the Participant or his Beneficiary, amounts transferred to an individual retirement account or annuity for the benefit of the Participant or
beneficiary, and amounts transferred to the Participant’s account in the ODEC and VMDAEC 401(k) Plan, and in such a manner to ensure that periods of benefit service are not included more than once in any determination of PRP accruals. 

(d) In the event a Participant in the Deferred Compensation PRP is eligible to receive more than one Deferred Compensation PRP Benefit, (for
example, in the case of a Participant who receives his Deferred Compensation PRP Benefit before the RS Plan benefit can be paid, and subsequently earns and becomes vested in another Deferred Compensation PRP Benefit), the Pension Limitation shall be
calculated for each benefit payment. In addition, any subsequent Deferred Compensation PRP Benefit shall be offset to take into account any Deferred Compensation PRP Benefit previously paid to the Participant by adding the differences between
(i) and (ii) described in the Pension Limitation definition for the previous payments to the amount under (ii) in the Pension Limitation definition for the current payment. 

(e) If a Participant attains the PRP stated vesting date, but continues to be employed by the Cooperative, any subsequent PRP accruals are
subject to the following conditions: 
  

	 	(i)	Any Subsequent Vesting Date established by the Board, if any, shall not be less than 24 months from the previous vesting date, provided that the Cooperative must notify NRECA in writing of the subsequent vesting date
within sixty (60) days of the prior vesting date; 

  

	 	(ii)	If no Subsequent Vesting Date is established, then further benefits under the Deferred Compensation PRP shall be calculated each Plan Year, and the first day of each Plan Year shall be treated for Section 4 as a
new Subsequent Vesting Date. Credits for payments under this section (ii) are available for application to RS billings at the end of the year for which payments are made. 

  
 5 

 (f) The named fiduciary of the RS Plan, or its designee, for purposes of the Cooperative’s
credit, has the sole discretion under the RS Plan to disregard amounts that significantly exceed the RS Plan’s salary increase assumptions and are large enough to substantially increase the cost of employee pensions that have not been reflected
in the RS Plan billing rate when such significant increases occur during the years preceding the date the Participant’s benefits commence under the RS Plan. To the extent such amounts are disregarded under the RS Plan, they shall be disregarded
for purposes of the Pension Limitation. This authority is limited to funding purposes and shall not be interpreted or construed as discretion with respect to this Plan for purposes of eligibility or benefits. 

(g) In determining the Participant’s pension benefit from the RS Plan, an increase in benefits due to a Special Early Retirement Plan
will not be included in the Pension Limitation calculation, unless such increase in benefits has been reflected in the RS Plan billing rate. 

(h) If a Participant incurs a RS Plan Benefit Election Date, the Participant’s Pension Limitation shall be determined as of such date and
the Participant’s benefit under this Plan shall be based on such amount with respect to participation in the RS Plan through the RS Plan Benefit Election Date. The lump sum value of such amount may, solely in the discretion of the Cooperative,
may be credited to an account. The account shall be adjusted based upon the investment experience of such amount whether held in trust or otherwise separately accounted for, to provide the basis pursuant to which earnings and losses may be
attributed and credited to the account of the Participant. The investment vehicle, vehicles, or funds for purposes of measuring the value of the amount credited to the account of the Participant shall be determined by the Cooperative. However, the
Participant, in the sole discretion of the Cooperative, may designate the investment vehicle to be used for purposes of measuring the value of the amount credited to the account of the Participant. Neither the trustee of the trust with respect to
which assets may be held nor the Cooperative shall be obligated to make actual investments in any such investment vehicles or funds. The account established pursuant to this subsection (i) shall be maintained for bookkeeping purposes only and
shall not represent any actual investment made by the Cooperative or a trust. The Participant shall at all times remain an unsecured creditor of the Cooperative. If the Cooperative decides not to credit an account based on investment experience as
described in this subsection (i), then the Participant’s benefit under this Plan, if and when paid, shall be based on such amount with respect to periods of participation in the RS Plan through the RS Plan Benefit Election Date. 

4. Benefit Forfeitable by Participant. 

(a) The benefit provided in Section 3 is subject to a substantial risk of forfeiture and shall be forfeited in its entirety if the
Participant’s employment with the Cooperative is terminated for any reason before the vesting date the Cooperative has specified in writing for each Participant under this Deferred Compensation PRP. If the Cooperative does not specify such a
date for any Participant then such date shall be the Normal Retirement Date. For purposes of this default rule, in the case of a Cooperative’s RS Plan that defines Normal Retirement Date as the earlier of an age or completion of a stated years
of service, participation, or similar measure, the Normal Retirement Age for vesting shall be the stated age. 
 (b) In any event, a
forfeiture shall not occur if the termination of the Participant’s employment with the Cooperative is caused by death or Disability. 

  
 6 

 (c) Participants’ eligibility for benefits under this plan shall not be transferrable to
another employer. The RS Plan will not provide a refund or other credit to a Cooperative as a result of the transfer of an employee who was previously covered under this PRP. 

(d) It is the intention of the Cooperative that the forfeiture provision of this Deferred Compensation PRP shall constitute a substantial risk
of forfeiture as defined in Section 457(f)(3)(B) of the Code. 
 (e) No vesting date established under a prior version of this Plan may
be changed by the adoption of the Amended and Restated Deferred Compensation PRP. 
 5. Timing and Form of Payment. 

(a) The Deferred Compensation Benefit shall be payable to the Participant (or if deceased to his Beneficiary) from the general assets of the
Cooperative in a lump sum payment immediately upon the lapse of the substantial risk of forfeiture specified by the Cooperative in writing pursuant to Section 4, above, but in no event later than two and a half months following the calendar
year in which the lapse of the substantial risk of forfeiture occurs, provided, however, that payments received by a Participant in the year following the year of the lapse of the risk of forfeiture shall be treated as includable income for the year
the risk of forfeiture lapsed. The Cooperative has the sole responsibility for compliance with the timely payment of PRP benefits. Payment of benefits may be delayed if calculation of the Pension Limitation cannot be performed for any reason
(including because necessary data is not available or has not been provided to NRECA and/or the Cooperative has not provided information regarding the Severance Pay Limit), but in no event will payment occur later than two and a half months
following the calendar year in which the lapse of the substantial risk of forfeiture occurs. If a Participant has one or more Subsequent Vesting Dates, then payment shall occur no later than two and a half months following the calendar year in which
each such Subsequent Vesting Date occurs. 
 (b) The Cooperative shall make arrangements to satisfy any federal, state or local income tax
withholding requirements, employment taxes, or other requirements applicable to the granting, crediting, vesting, or payment of benefits under the Plan. There shall be deducted from any payment under the Plan or any other compensation payable to the
Participant all taxes which are required to be withheld by the Cooperative in respect to such payment or the Plan. Determining withholding and payment of taxes shall be the responsibility of the Cooperative and not NRECA. 

6. Termination and Amendment. The Board may amend any or all provisions of this Plan at any time by written instrument
identified as an amendment effective as of a specified date. The Deferred Compensation PRP may be terminated in whole or in part at any time by action of the Board. However, no such termination or amendment shall reduce any benefit accrued by a
Participant in this Plan prior to the effective date of the termination or amendment. 

  
 7 

 7. Assets of the Plan and Benefit Payments. The benefits under this Deferred
Compensation PRP shall be payable from the general assets of the Cooperative. The Cooperative may elect to place assets in a grantor trust to provide itself with a source of funds to meet its liabilities under the Plan, provided that the assets of
such trust remain subject to the general creditors of the Cooperative. No part of the Participant’s benefit shall be liable for the debts, contracts, or engagements of any Participant, nor shall a Participant’s benefit be subject to
execution, levy, attachment, or garnishment. No Participant (or his or her successor or assigns) shall have any right to alienate, anticipate, sell, transfer, encumber, or assign any benefits or payments hereunder in any manner whatsoever. 

8. Death of Participant. 

(a) Death Prior to Vesting Date. In the event of a Participant’s death prior to his attainment of his Initial Vesting Date, the
amount of vested benefits to be paid to the Participant’s Beneficiaries is determined using the same calculation methodology used in the RS Plan to determine the amount payable to the Participant’s beneficiaries from the RS Plan. 

(b) Death Following Vesting Date. In the event of the death of a Participant who has attained an Initial Vesting Date or Subsequent
Vesting Date and has received a PRP benefit, the death benefit payable by the Deferred Compensation PRP is calculated using the same methodology as used by the RS Plan to determine the amount of a death benefit payable from the RS Plan. Such
calculation shall apply the 50% reduction (if applicable) to the amount of the PRP benefit in the same manner as is applied to the RS Plan benefit. In the event that the total of all PRP benefits paid previously to the Participant, plus the amount
due as a result of death exceed 50% of the total of the RS Plan benefit, no adjustment of the PRP benefit previously paid will be made. The PRP benefit will be separately calculated as of the date of death and include the period of service measured
from the date of the most recent calculation and payment of a PRP benefit. 
 (c) Beneficiary. A Participant’s Beneficiary shall
be designated at such times and on the forms prescribed by the Board. If the Participant fails to name a Beneficiary, the Beneficiary shall be the Participant’s beneficiary under the RS Plan. 

9. Disability. A Participant who becomes Disabled, and whose participation in the RS Plan continues under the RS Plan waiver
will cease accruing PRP benefits as of the date on which he is determined to be Disabled. The PRP benefit will be calculated as of the date on which the Participant is declared Disabled, and the Cooperative will distribute the PRP benefit to the
Participant within 60 days, but in no event less than 2 1⁄2 months following the end of the calendar year in which the PRP benefit has vested due to
Disability. 
 10. General Administrative Powers and Duties. 

(a) General administration of the Plan shall be placed in the Board. The Board shall have the power to take all actions required to carry out
the provisions of the Deferred Compensation PRP and shall further have the following powers and duties which shall be exercised in a manner consistent with the provisions of the Deferred Compensation PRP: 

  
 8 

	 	(i)	To construe and interpret the provisions of the Deferred Compensation PRP and make rules and regulations under the Deferred Compensation PRP to the extent deemed advisable by the Board; 

 

	 	(ii)	To decide all questions as to eligibility to become a Participant in the Deferred Compensation PRP and as to the rights of Participants under the Deferred Compensation PRP; 

 

	 	(iii)	To file or cause to be filed all such reports and other statements as may be required by any federal or state statute, agency or authority for the Deferred Compensation PRP; and 

 

	 	(iv)	To do such other acts as it deems necessary to administer the Deferred Compensation PRP in accordance with its provisions or as may be required by law. 

(b) Notwithstanding any provision of this Plan, NRECA is the sole authority with respect to application of any credit to the Cooperative as an
offset to the Cooperative’s RS Plan billings. NRECA may reduce or eliminate the amount of any credit if in its judgment the Deferred Compensation PRP benefit is not fully funded as a result of actions by the Cooperative, including, but not
limited to, an unreasonable increase in a Participant’s compensation in years preceding the date the Participant’s substantial risk of forfeiture lapses, or if the Cooperative approves participation of an employee who does not satisfy
eligibility requirements under this Plan and federal law. This authority is limited to funding purposes and shall not be interpreted or construed as discretion with respect to this Plan for purposes of eligibility or benefits. 

11. Grant of Discretion. In discharging the duties assigned to it under the Deferred Compensation PRP, the Board and its
delegates have the discretion and final authority to interpret and construe the terms of the Deferred Compensation PRP; to determine coverage and eligibility for and amount of benefits under the Deferred Compensation PRP; to adopt, amend, and
rescind rules, regulations and procedures pertaining to its duties under the Deferred Compensation PRP and the administration of the Deferred Compensation PRP; and to make all other determinations deemed necessary or advisable for the discharge of
its duties or the administration of the Deferred Compensation PRP. The discretionary authority of the Board and its delegates is final, absolute, conclusive and exclusive, and binds all parties so long as exercised in good faith. Any judicial review
of any decision of the Board or its delegates shall be limited to the arbitrary and capricious standard of review. 
 12. Claim
Adjudicator. All claims for benefits under the Deferred Compensation PRP shall be determined by the Cooperative, which shall be the administrator and named fiduciary of the Plan for purposes of Section 503 of ERISA with respect to
adjudication of such claims for benefits under the Deferred Compensation PRP. 

  
 9 

 13. Claim Procedure. Upon the submission of a claim for benefits under the Deferred
Compensation PRP to the Cooperative, notice of a decision with respect to the claim shall be furnished within 90 days. If circumstances require an extension of time for processing the claim, written notice of the extension shall be furnished by the
Cooperative to the claimant prior to the expiration of the initial 90 day period. The notice of extension shall indicate the circumstances requiring the extension and the date by which the notice of the decision with respect to the claim shall be
furnished Commencement of benefit payment shall constitute notice of approval of a claim to the extent of the amount of approved benefit. If such claim is wholly or partially denied, such notice shall be in writing and worded in a manner calculated
to be understood by the claimant and shall set forth (a) the reason or reasons for the denial, (b) specific reference to pertinent provisions of the Deferred Compensation PRP on which the denial was based, (c) a description of any
additional material or information necessary for the claimant to perfect the claim and an explanation of why such material or information is necessary, and (d) an explanation of the claims review procedure. If the claimant is not notified of
the decision in accordance with this Section, such claim shall be deemed denied and the claimant shall then be permitted to proceed with the claims review procedure provided below. 

14. Claims Review Procedure. 

(a) Within 90 days following receipt of notice of a claim denial, or within 90 days following close of the 90 day period referred to in
Section 13 of the Plan, the claimant must file an appeal of the denial of a claim in writing with the Board requesting a review of such denial. 

(b) Prior to a decision on the appeal by the Board, the claimant or the claimant’s duly authorized representative may review pertinent
documents and submit issues and comments in writing for consideration. The issues and comments submitted by a claimant or the claimant’s duly authorized representative shall supplement the administrative record on which the appeal is to be
decided and should contain all of the additional information the claimant wishes to be considered in the review. 
 (c) Within 60 days
following receipt of an appeal, the Board shall render a written decision. If circumstances require an extension of time for reviewing an appeal, written notice of the extension shall be furnished to the claimant or the claimant’s authorized
representative prior to the commencement of the extension. If an extension of time is elected, the Board shall render its decision within 120 days after receipt of the appeal. 

(d) The Board’s decision on the appeal shall be in writing, worded in a manner calculated to be understood by the claimant, and shall set
forth (a) the reason or reasons for the decision and (b) specific reference to pertinent provisions of the plan on which the decision is based. 

(e) Any action brought for judicial review of the Board’s decision may be made only after the claims review process is completed and must
commence within one year of the date on which the Board renders its final decision to the claimant in writing. 
 15. Notices.

 (a) The Cooperative shall notify NRECA in writing upon the occurrence of any of the following events: 

  
 10 

	 	(i)	The date each Participant is vested in the Deferred Compensation PRP benefit and due a payment; 

  

	 	(ii)	The payment of any benefits to a Participant in the Deferred Compensation PRP, including the amount and time of the benefit payment; 

 

	 	(iii)	The adoption, amendment or termination of the Deferred Compensation PRP, including a copy of the signed Deferred Compensation PRP as adopted or amended and the Board resolution authorizing such action or the resolution
authorizing the termination of the Deferred Compensation PRP; and 

  

	 	(iv)	The date on which the Participant incurs an RS Plan Benefit Election Date under the RS Plan. 

 (b) All notices
sent to NRECA shall be mailed to: 
 Debi Strong 

Deferred Compensation Products Group 

Insurance & Financial Services Department 

National Rural Electric Cooperative Association 

4301 Wilson Boulevard 

Arlington, Virginia 22203 

16. No Right to Employment. Nothing in the Deferred Compensation PRP shall constitute, nor be interpreted
to constitute, a promise or representation of the employment or continued employment of any individual by the Cooperative or other entity. 

17. No Waiver or Estoppel. No term, condition or provision of the Deferred Compensation PRP shall be deemed to have been waived,
and there shall be no estoppel against the enforcement of any provision of the Deferred Compensation PRP, except by written instrument of the party charged with such waiver or estoppel. No such written waiver shall be deemed a continuing waiver
unless specifically stated therein, and each such waiver shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.

 18. Misstatements of Information. In the event of any misstatement of any fact affecting benefits and eligibility
for benefits, the true facts shall be used to determine eligibility and benefits. 
 19. Applicable Law. The provisions of
this Deferred Compensation PRP shall be construed according to the laws of the Commonwealth of Virginia, except as preempted by Federal law and in accordance with the Code and ERISA. 

  
 11 

 20. Code Section 409A. The Plan is intended to be exempt from
Section 409A of the Code as a short-term deferral plan because benefits under the Plan must be made no later than 2 1⁄2 months following the
calendar year in which the lapse of the substantial risk of forfeiture occurs. However, to the extent that for any reason any benefit provided under the Plan is treated as deferred compensation for purposes of Section 409A of the Code, then
notwithstanding any provision to the contrary in this Deferred Compensation PRP, each provision in this Deferred Compensation PRP shall be interpreted to comply with Section 409A of the
Code and the guidance issued thereunder. Any provision of the Deferred Compensation PRP that would conflict with such requirements shall not be valid or enforceable. 

IN WITNESS WHEREOF, the Cooperative has caused this document to be executed, to be effective as of January 1, 2015. 
  

							
		 		 	OLD DOMINION ELECTRIC COOPERATIVE
				
	Date: 12/2/2014	 		 	By:	 	/s/ Jackson E. Reasor

  
 12 

 SCHEDULE A 

DEFERRED COMPENSATION PENSION RESTORATION PLAN 

LIST OF GRANDFATHERED PARTICIPANTS AND VESTING DATES 

In accordance with Sections 2, 3, and 4 of the Deferred Compensation Pension Restoration Plan, as amended and restated effective
January 1, 2015 (the “Plan”), Old Dominion Electric Cooperative (the “Cooperative”) has specified the following individuals as covered employees, and the PRP vesting dates for the Participants below. If a Participant in the
Plan does not have a specified vesting date, then the vesting date shall be the normal retirement date for the Participant under the Retirement Security Plan (the “RS Plan”). For purposes of this default rule, in the case of a
Cooperative’s RS Plan that defines Normal Retirement Date as the earlier of an age or completion of a stated years of service, participation, or similar measure, the Normal Retirement Age for vesting shall be the stated age as set forth in
Section 4(a) of the Plan. Any employee of the Cooperative that is otherwise eligible to participate in the Deferred Compensation Pension Restoration Plan, but who is not listed as a covered employee below will not be eligible for benefits under
the plan. Eligibility is not transferrable to another employer or Cooperative that sponsors their own plan. Additionally, an individual listed below who does not also satisfy the eligibility requirements, or whose Cooperative is not eligible for a
funding credit for the individual through the RS Plan, shall not be considered eligible to participate. 
 PRP Schedule 

 

			
	 PRP Participant
	  	 Vesting Date

		
	1. Jackson E. Reasor	  	November 13, 2014
		
	2. Robert L. Kees	  	October 30, 2014
		
	3. D. Richard Beam	  	October 26, 2019

 For purposes of Section 4 of the Plan, the vesting date set forth herein is the date as of which there no longer is a
substantial risk of forfeiture relating to the PRP Benefit of the listed Participant. 
  

							
		 		 	OLD DOMINION ELECTRIC COOPERATIVE
				
	Date: 12/2/2014	 		 	By:	 	/s/ Jackson E. ReasorEXHIBIT 10.25

SUBSCRIPTION AGREEMENT

 

THIS SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of February 4, 2015 by and between Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), and the investor listed on Schedule A hereto (each, an “Investor” and together, the “Investors”).

 

AGREEMENT

 

In consideration for the mutual promises and covenants herein, the parties agree as follows:

 

WHEREAS, the Company is offering up to approximately three million shares of its Series A Common Stock, par value $0.0001 per share (the "Series A Shares") for $3.90 per share (the "Purchase Price"), in an overnight underwritten public offering;

 

WHEREAS, the Company is hereby simultaneously offering its Series A Shares at a price per share equal to the Purchase Price in a private placement to a limited number of accredited investors, including certain of its officers, directors and affiliates; and

 

WHEREAS, the undersigned desires to subscribe for and purchase the number of Series A Shares set forth on Schedule A hereto.

 

SECTION 1 - PURCHASE AND SALE OF SERIES A SHARES

1.1               Purchase and Sale of Series A Shares. The Company has authorized the issuance and sale, in accordance with the terms hereof, of its Series A Shares. On the terms and subject to the conditions set forth in this Agreement, at the Closing (as defined below), the Company agrees to issue to each Investor, and the Investor agrees to purchase from the Company, such number of Series A Shares as is set forth on the line marked “Number of Series A Shares Purchased” on Schedule A (the "Purchased Shares"). The Company will sell Series A Shares to more than one Investor, each of whom will enter into Subscription Agreement substantially identical to this one.

       

1.2              Closing. The purchase and sale of the Series A Shares shall take place at the closing (the “Closing”) which shall take place remotely via exchange of documents and signatures at 10:00 a.m. Eastern Time three business days immediately following execution and delivery of this Agreement, or at such other place and time as may be agreed to among the Company and the Investors. At the Closing, the Company shall deliver to each of the Investors purchasing Series A Shares a certificate or certification representing such number of Purchased Shares, against receipt of a check subject to collection or a wire transfer in immediately available funds of the purchase price, to an account designated by the Company.

 

SECTION 2 - REPRESENTATIONS AND WARRANTIES

OF THE COMPANY

 

The Company represents and warrants to each Investor as follows:

 

2.1              Existence of Company. The Company is a duly organized Delaware corporation. The Company is validly existing in all jurisdictions where it conducts its business.

 

2.2              Authority to Execute. The execution, delivery and performance by the Company of this Agreement and the issuance of the Series A Shares are within the Company’s corporate powers, have been duly authorized by all necessary corporate action, do not and will not conflict with any provision of law or organizational document of the Company (including its Certificate of Incorporation or Bylaws) or of any agreement or contractual restrictions binding upon or affecting the Company or any of its property and need no further stockholder or creditor consent.

 

2.3              No Stockholder Approval Required. No approval of the Company’s stockholders is required for (i) the entry by the Company into this Agreement, or (ii) the issuance of the Series A Shares contemplated by this Agreement.

 

2.4             Valid Issuance. The Series A Shares will be, validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under, applicable state and federal securities laws and liens or encumbrances created by or imposed by the Investor. Assuming the accuracy of the representations of the Investor in Section 3 of this Agreement, and the Series A Shares will be issued in compliance with all applicable federal and state securities laws.

 

2.5              Binding Obligation. This Agreement is, a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization and similar laws affecting creditors’ rights generally and to general equitable principles.

 

2.6             SEC Reports.The Company has filed all forms, reports, schedules, proxy statements, registration statements and other documents (including all exhibits thereto) required to be filed by it with the Securities and Exchange Commission (the “SEC”) pursuant to the federal securities laws and the SEC rules and regulations thereunder, together with all certifications required pursuant to the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) (as they have been amended since the time of their filing, including all exhibits thereto, the “SEC Reports”). Each of the SEC Reports complied in all material respects with the applicable requirements of the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley Act and the rules and regulations of the SEC under all of the foregoing. None of the SEC Reports contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

SECTION 3 - REPRESENTATIONS AND WARRANTIES

OF THE INVESTORS

 

Each Investor represents and warrants to the Company as follows:

 

3.1              Authorization; Binding Obligations. The Investor has full power and authority to enter into this Agreement and this Agreement constitutes a valid and legally binding obligation of the Investor, enforceable against the Investor in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization and similar laws affecting creditors’ rights generally and to general equitable principles.

 

3.2              Accredited Investor. The Investor is an “accredited investor” within the meaning of SEC Rule 501 of Regulation D promulgated under the Securities Act.

 

3.3              Investment for Own Account. The Series A Shares are being acquired for the Investor's own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act.

 

2

3.4              Knowledge and Experience. The Investor has such knowledge and experience in financial and business matters that (s)he is capable of evaluating the merits and risks of an investment in the Series A Shares and of making an informed investment decision with respect thereto, has the ability and capacity to protect his/her interests and can bear the economic risk of the acceptance of the Series A Shares, including a total loss of his/her investment.

 

3.5              Opportunity to Ask Questions. The Investor has had the opportunity to ask questions and receive answers from the Company or any authorized person acting on its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed by the Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify the accuracy of the information received by the Investor. In connection therewith, the Investor acknowledges that the Investor has had the opportunity to discuss the Company’s business, management and financial affairs with the Company’s management or any authorized person acting on its behalf.

 

3.6.            Receipt of Information. The Investor has received and reviewed all the information concerning the Company and the Series A Shares, both written and oral, that the Investor desires. Without limiting the generality of the foregoing, the Investor has been furnished with or has had the opportunity to acquire, and to review: all information, both written and oral, that the Investor desires with respect to the Company’s business, management, financial affairs and prospects. In determining whether to make this investment, the Investor has relied solely on the Investor's own knowledge and understanding of the Company and its business and prospects based upon the Investor’s own due diligence investigations and the Company’s filings with the SEC.

 

SECTION 4 - MISCELLANEOUS

 

4.1              No Waiver; Cumulative Remedies. No failure or delay on the part of any party to this Agreement in exercising any right or remedy under, or pursuant to, this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, remedy or power preclude other or further exercise thereof, or the exercise of any other right, remedy or power. The remedies in this Agreement are cumulative and are not exclusive of any remedies provided by law.

 

4.2              Amendments and Waivers. Except as otherwise expressly set forth in this Agreement, any term of this Agreement may be amended (either retroactively or prospectively) with the written consent of the Company and the Investor. Any amendment effected in accordance with this Section 4.2 shall be binding upon each Investor, each future holder of the Purchased Shares and the Company.

 

4.3               Notices, Etc. All notices, requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument delivered in person; sent by facsimile transmission; sent by electronic mail; duly sent by first class registered or certified mail, return receipt requested, postage prepaid; or duly sent by overnight delivery service (e.g., Federal Express) addressed to such party (i) if to the Company, at the address, fax number or electronic mail address, as applicable, set forth on the signature page hereof or (ii) if to an Investor, at the address, fax number or electronic mail address, as applicable, set forth on Schedule A hereto, or at such other address, fax number or electronic mail address as may hereafter be designated in writing by the addressee to the sender. All such notices, advises and communications shall be deemed to have been received: (a) in the case of personal delivery, on the date of such delivery; (b) in the case of facsimile or electronic mail transmission, on the date of transmission; and (c) in the case of mailing or delivery by service, on the date of delivery as shown on the return receipt or delivery service statement.

 

3

4.4              Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California or of any other state. The Company and each Investor consent to personal jurisdiction in San Francisco County, California.

 

4.5              Severability. If any term in this Agreement is held to be illegal or unenforceable, the remaining portions of this Agreement shall not be affected, and this Agreement shall be construed and enforced as if this Agreement did not contain the term held to be illegal or unenforceable.

 

4.6               Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and each Investor and their respective successors and assigns.

 

4.7               Registration Rights. Following the expiration of the Company's lock-up period as set forth in that certain Underwriting Agreement dated on or about February 4, 2015, by and between the Company and the MLV & Co. LLC, the Company shall use commercially reasonably efforts to (i) file with the SEC a registration statement covering the resale of the Purchased Shares by the Investor, (ii) cause the SEC to declare such registration statement effective, (iii) maintain the effectiveness of such registration statement, and (iv) within a reasonable time following the effectiveness of such registration statement, to cause its stock transfer agent to remove the restrictive legend on the certificate(s) representing the Purchased Shares, provided however, that notwithstanding anything contained herein, the Company shall have the privilege to postpone, for one time only, the filing and/or effectiveness of such registration statement for a reasonable period of time (not exceeding 120 days) if the Company furnishes the Investor with a certificate signed by the Chairman of the Board or the Chief Executive Officer of the Company stating that, in its good faith judgment, the Company’s board of directors has determined that filing of the registration statement or causing the SEC to declare the registration statement effective would adversely affect a material financing.

 

4.8               Transfer of Series A Shares. Notwithstanding the legend required to be placed on the Series A Shares by applicable law, no registration statement shall be necessary: (a) for a transfer of Series A Shares to the respective estate of each Investor or for a transfer of Series A Shares by gift, will or intestate succession of each Investor to his or her spouse or to the siblings, lineal descendants or ancestors each Investor or his or her spouse, if the transferee agrees in writing to be subject to the terms hereof to the same extent as if he or she were the original Investor hereunder; or (b) for a transfer of Series A Shares pursuant to SEC Rule 144 or any successor rule, or for a transfer of Series A Shares pursuant to a registration statement declared effective by the SEC under the Securities Act relating to the Purchased Shares, subject to the condition precedent in case of both (a) and (b) to the Company providing an opinion furnished by the Company's counsel to the effect that such transfer is exempt from the registration requirements of the Securities Act.

 

4.9              Survival of Representations and Warranties. The representations and warranties of the parties contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement indefinitely, and shall in no way be affected by any investigation of the subject matter thereof made by or on behalf of the other parties.

 

4.10            California Commissioner of Corporations. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION FOR SUCH SECURITIES PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATIONS BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

 

4

[Remainder of Page Intentionally Left Blank]

 

 

5

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as of the date first written above.

	 	
ASTERIAS BIOTHERAPEUTICS, INC.

	 
	 	 	 	 
	 	
By:

		 
	 	 	
Name: Pedro Lichtinger

	 
	 	 	
Title:  Chief Executive Officer

	 

Address/ E-mail Address for Notice:

230 Constitution Drive

Menlo Park, California 94025

plichtinger@asteriasbio.com

	 	
INVESTOR:

	 
	 	 	 	 
	 	
By:

	   	 
	 	
 

	Name:	 
	 	
 

	Title:	 

 

[SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT]

 

SCHEDULE A

	
NAME OF INVESTOR (Please Print):

	 	 	 	 
	 	 	 	 	 
	
DATE:

	 	 	 	 
	 	 	 	 	 
	
ADDRESS FOR NOTICE (Please Print)

	 	 	 	 
	 	 	 	 	 
	
Street:

	 	 	 	 
	 	 	 	 	 
	
City, State:

	 	 	 	 
	 	 	 	 	 
	
Zip Code:

	 	 	 	 
	 	 	 	 	 
	
Attention:

	 	 	 	 
	 	 	 	 	 
	
(If other than an individual)

	 	 	 	 
	 	 	 	 	 
	
Fax:

	 	 	 	 
	 	 	 	 	 
	
Home Phone No:

	 	 	 	 
	 	 	 	 	 
	
Work Phone No.:

	 	 	 	 
	 	 	 	 	 
	
Cellular Phone No.:

	 	 	 	 
	 	 	 	 	 
	
E-Mail Address:

	 	 	 	 
	 	 	 	 	 
	
SSN/Tax I.D. No:

	 	 	 	 
	 	 	 	 	 
	
Number of Series A Shares Purchased:

	 	 	 	 
	 	 	 	 	 
	
Aggregate Purchase Price:

	 	$

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]